Ruedi Aebersold, Edouard C. Nice, Mathias Uhlén, Seong Beom Ahn, Joshua LaBaer, Joshua L Justice, Yves Vandenbrouck, Gilbert S. Omenn, Stephen R. Pennington, Jennifer E. Van Eyk, Emma Lundberg, Peipei Ping, J. C. Waddington, Sara A. Wennersten, Sanjeeva Srivastava, Robert L. Moritz, Marc R. Wilkins, Amos Marc Bairoch, Rebekah L. Gundry, Ulrike Kusebauch, György Marko-Varga, Maggie P.Y. Lam, Fuchu He, Susan T. Weintraub, Peter Stewart, Markus Kostrzewa, Cecilia Lindskog, Christopher M. Overall, Nuno Bandeira, Mark S. Baker, Juan Antonio Vizcaíno, Fernando J. Corrales, Sudhir Srivastava, Jochen M. Schwenk, Subash Adhikari, Eric W. Deutsch, Ileana M. Cristea, Charles Pineau, Gilberto B. Domont, Magnus Palmblad, Lydie Lane, Henry Rodriguez, Fábio C. S. Nogueira, Daniel W. Chan, Young Ki Paik, Michael Snyder, Instituto de Salud Carlos III, Comunidad de Madrid, National Institutes of Health (US), Canada Research Chairs, Wellcome Trust, Knut and Alice Wallenberg Foundation, Fundaçao Capes (Brasil), Conselho Nacional de Desenvolvimento Científico e Tecnológico (Brasil), Cancer Council NSW (Australia), Cancer Institute NSW (Australia), Stanford University, Macquarie University, Monash University [Melbourne], Institute for Systems Biology [Seattle] (ISB), Centre médical universitaire de Genève (CMU), University of Michigan [Ann Arbor], University of Michigan System, University College Dublin [Dublin] (UCD), Yonsei University, University of British Columbia (UBC), Centro Nacional de Biotecnología [Madrid] (CNB-CSIC), Consejo Superior de Investigaciones Científicas [Madrid] (CSIC), Princeton University, Cedars-Sinai Medical Center, Royal Institute of Technology [Stockholm] (KTH ), Uppsala University, Johns Hopkins University School of Medicine [Baltimore], Arizona State University [Tempe] (ASU), National Institutes of Health [Bethesda] (NIH), National Cancer Institute [Bethesda] (NCI-NIH), Bruker Daltonik GmbH, David Geffen School of Medicine [Los Angeles], University of California [Los Angeles] (UCLA), University of California (UC)-University of California (UC), University of Nebraska Medical Center, University of Nebraska System, Indian Institute of Technology Bombay (IIT Bombay), Pontifícia Universidade Católica do Rio de Janeiro (PUC-Rio), Laboratoire de Biologie à Grande Échelle (BGE - UMR S1038), Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut de Recherche Interdisciplinaire de Grenoble (IRIG), Direction de Recherche Fondamentale (CEA) (DRF (CEA)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Direction de Recherche Fondamentale (CEA) (DRF (CEA)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université Grenoble Alpes (UGA), University of Colorado Anschutz [Aurora], European Bioinformatics Institute [Hinxton] (EMBL-EBI), EMBL Heidelberg, University of New South Wales [Sydney] (UNSW), University of California [San Diego] (UC San Diego), University of California (UC), Department of Computer Science and Engineering [Univ California San Diego] (CSE - UC San Diego), Lund University [Lund], University of Texas Health Science Center, The University of Texas Health Science Center at Houston (UTHealth), Institut de recherche en santé, environnement et travail (Irset), Université d'Angers (UA)-Université de Rennes (UR)-École des Hautes Études en Santé Publique [EHESP] (EHESP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), Leiden University Medical Center (LUMC), Universiteit Leiden, Stanford University School of Medicine [CA, USA], Universität Zürich [Zürich] = University of Zurich (UZH), Stanford School of Medicine [Stanford], Stanford Medicine, Stanford University-Stanford University, HAL UR1, Admin, Biocomputing Unit [Madrid], University of California-University of California, University of California, Department of Computer Science and Engineering [San Diego] (CSE-UCSD), Université d'Angers (UA)-Université de Rennes 1 (UR1), and Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-École des Hautes Études en Santé Publique [EHESP] (EHESP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique )
© The Author(s) 2020, The Human Proteome Organization (HUPO) launched the Human Proteome Project (HPP) in 2010, creating an international framework for global collaboration, data sharing, quality assurance and enhancing accurate annotation of the genome-encoded proteome. During the subsequent decade, the HPP established collaborations, developed guidelines and metrics, and undertook reanalysis of previously deposited community data, continuously increasing the coverage of the human proteome. On the occasion of the HPP’s tenth anniversary, we here report a 90.4% complete high-stringency human proteome blueprint. This knowledge is essential for discerning molecular processes in health and disease, as we demonstrate by highlighting potential roles the human proteome plays in our understanding, diagnosis and treatment of cancers, cardiovascular and infectious diseases., Parts of this work were supported by grants to ProteoRed PRB3-ISCIII, PT17/0019/0001 Comunidad de Madrid Grant B2017/BMD-3817 (F.J.C.); Korean Ministry of Health and Welfare HI13C2098 and HI16C0257 (Y.K.P.); NIH grants P30ES017885 and U24CA210967 (G.S.O.), 5U01HL-13104204, PADOM-SPO11347 and PARYB-SPO112285 (M.P.S.); NCI CPTAC U24CA210985 and NCI EDRN U24CA115102 (D.W.C.); NIH National Institute of General Medical Sciences R01GM087221 (E.W.D./R.L.M.) and R24GM127667 (E.W.D.); NIH National Institute on Aging U19AG023122 (R.L.M.); NSF DBI-1933311 (E.W.D.); CIHR COVID-19 Rapid Research Funding (F20-01013), CIHR Foundation Grant FDN:14840 and Canada Research Chair (C.M.O.); Investissement d’Avenir Infrastructures Nationales en Biologie et Santé ANR-10-INBS-08 (Proteomics French Infrastructure ProFI (Y.V.); Wellcome Trust WT101477MA and 208391/Z/17/Z (J.A.V.); Knut and Alice Wallenberg Foundation (M.U., C.L., J.M.S., E.L.); Brazilian CAPES 88887.130697, CNPq 440613/2016-7, FAPERJ E-26/210.173/2018 (G.B.D.) and FAPERJ E-26/202.650/2018 (F.C.S.N.), Australian Commonwealth NCRIS (M.S.B.); NHMRC 1010303 (M.S.B., E.C.N.); Cancer Council NSW RG19-04 (M.S.B., S.B.A., E.C.N.); Cancer Institute NSW Fellowship 15/ECF/1-38 (S.B.A.), Sydney Vital CINSW Translational Cancer Research Centre grant (M.S.B., S.B.A., S.A.), ‘Fight on the Beaches’ (M.S.B., S.B.A., E.C.N., S.A.) funding and an International Macquarie Research Excellence Scholarship (S.A.). M.S.B. thanks the Faculty of Medicine, Stanford University for a sabbatical visiting professorship.